Global health agencies are closely monitoring the ongoing Ebola outbreak in parts of Africa as concerns grow around the rare Bundibugyo strain of the virus. While Ebola outbreaks have occurred before, experts say the current situation is particularly worrying because of the limited vaccine protection available against this variant and the increasing risk of international spread through global travel.
The World Health Organization (WHO) and multiple public health agencies have intensified surveillance and preparedness measures after cases linked to the outbreak were reported in Uganda and neighbouring regions. Several countries, including India, have already strengthened airport monitoring and emergency response systems.
According to infectious disease experts, one of the biggest concerns surrounding the new Ebola variant is the absence of a fully approved vaccine specifically designed for the Bundibugyo strain.
“Previous Ebola outbreaks were easier to manage because vaccines and treatments had already shown effectiveness against certain strains. The current variant is more challenging because there is limited real-world protection data available,” explains Dr. Raman Gangakhedkar, former head scientist at the Indian Council of Medical Research (ICMR).
Ebola is a severe viral disease that spreads through direct contact with infected blood, bodily fluids, or contaminated surfaces. Symptoms usually begin suddenly and may include high fever, severe weakness, vomiting, diarrhoea, muscle pain, and in severe cases, internal or external bleeding.
Although Ebola is not considered airborne like COVID-19, health agencies remain concerned because delayed detection can allow infected travellers to unknowingly spread the virus across borders.
Another major concern is the high fatality rate associated with Ebola outbreaks. Depending on the strain and healthcare access, Ebola has historically recorded mortality rates ranging from 25% to 90%.
Experts say weak healthcare systems in outbreak-hit regions can make containment more difficult. Limited access to isolation centres, delayed diagnosis, and misinformation may further increase transmission risks.
“Rapid identification, isolation, contact tracing, and public awareness are extremely important during Ebola outbreaks. Even one undetected case can trigger wider transmission if response systems are slow,” says Dr. Gangakhedkar.
Global vaccine development efforts are currently underway. Researchers from several countries, including Russia, the United Kingdom, and the United States, are working on experimental vaccines targeting the Bundibugyo strain. However, experts warn that large-scale deployment may still take several months.
The outbreak has also triggered heightened airport screening and surveillance measures worldwide. Countries are focusing on monitoring travellers arriving from affected regions and training healthcare workers to identify symptoms early.
Public health experts stress that panic is unnecessary, but awareness is critical. They advise travellers to avoid misinformation and follow official health advisories issued by governments and international agencies.
Doctors also warn people not to ignore symptoms such as fever, vomiting, unexplained weakness, or bleeding if they have recently travelled to affected areas or come into contact with suspected patients.
The WHO continues to emphasise international cooperation, early reporting, and stronger healthcare preparedness to prevent the outbreak from escalating further.
As the world continues recovering from the impact of COVID-19, health agencies say the Ebola outbreak serves as another reminder of how quickly infectious diseases can become global concerns if surveillance and preparedness systems are not strengthened in time.
Leave a comment